The Impact of Therapy Dogs on Anxiety and Emotional Management in the Pediatric Emergency Department

NCT ID: NCT04942678

Last Updated: 2022-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

41 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-25

Study Completion Date

2021-07-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the impact of therapy dogs on children's anxiety and emotional management during a visit to the pediatric emergency department.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Emotional Regulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pediatric patients ages 4-7 years old in the Pediatric Emergency Department

Patients will receive a 10-minute visit with therapy dog and child life handler

10-minute visit with therapy dog and child life specialist handler

Intervention Type BEHAVIORAL

A visit from a therapy dog and child life specialist will occur which will last for approximately 10 minutes. Parents and patients will be asked to sanitize their hand prior to the visit. The child life specialist will be instructed to have ad lib conversation with the family. The dog will remain on a leash during the visit. The patient will be free to pet the therapy dog if they wish.

Pediatric patients ages 8-12 years old in the Pediatric Emergency Department

Patients will receive a 10-minute visit with therapy dog and child life handler

10-minute visit with therapy dog and child life specialist handler

Intervention Type BEHAVIORAL

A visit from a therapy dog and child life specialist will occur which will last for approximately 10 minutes. Parents and patients will be asked to sanitize their hand prior to the visit. The child life specialist will be instructed to have ad lib conversation with the family. The dog will remain on a leash during the visit. The patient will be free to pet the therapy dog if they wish.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

10-minute visit with therapy dog and child life specialist handler

A visit from a therapy dog and child life specialist will occur which will last for approximately 10 minutes. Parents and patients will be asked to sanitize their hand prior to the visit. The child life specialist will be instructed to have ad lib conversation with the family. The dog will remain on a leash during the visit. The patient will be free to pet the therapy dog if they wish.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with a SUD score of 30 or higher indicated by the caregiver

Exclusion Criteria

* Active infection: abscesses, fever, respiratory issues, vomiting
* Patients presenting for burn care, dog bite, ESI triage category 1 or 2, or transferred from outside facilities
* Sterile procedures
* Oncology patients / patients with known neutropenia in past medical history
* Parent/caregiver or patient fear of dogs
* Parent/caregiver or patient allergy to dogs
* Dog bite injury
* Already underwent procedure during their visit
Minimum Eligible Age

4 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Louisville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michelle D. Stevenson

Professor of Pediatrics Director of Research Development, Department of Pediatrics, University of Louisville Norton Children's Medical Group, Affiliated with the U of L School of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michelle D Stevenson, MD, MS

Role: PRINCIPAL_INVESTIGATOR

University of Louisville

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Norton Children's Hospital

Louisville, Kentucky, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21.0190

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ACEs Referral From PED
NCT06574633 COMPLETED NA
Nighttime Communication Study
NCT01836601 COMPLETED NA